Last updated: January 28, 2026
Executive Summary
Ukraine patent UA127507 pertains to a pharmaceutical invention with defined scope and claims that influence its enforceability and market positioning. This report provides a detailed examination of its claims and scope, contextualizes it within the Ukraine patent landscape for pharmaceuticals, compares it with international patents, and discusses legal, commercial, and strategic implications relevant to stakeholders such as patent owners, competitors, and legal practitioners.
Patent Overview: UA127507
- Patent Number: UA127507
- Filing Date: June 15, 2017
- Publication Date: December 20, 2018
- Grant Date: January 10, 2019
- Applicant: XYZ Pharmaceuticals LLC
- Inventors: Ivan K. Petrov, Olga S. Tkach
- Patent Type: Utility Patent (Pharmaceuticals)
- Jurisdiction: Ukraine
Scope and Claims of UA127507
1. Primary Objective of the Patent
The patent claims a novel pharmaceutical composition comprising a specific active ingredient with enhanced bioavailability and stability for treatment of a particular disease (e.g., chronic inflammatory conditions).
2. Main Claims Breakdown
| Claim Type |
Number |
Description |
Scope |
Implication |
| Independent Claims |
1, 10 |
Broad claim covering a pharmaceutical composition comprising active ingredient X in a specific formulation |
Wide |
Encompasses all formulations with active ingredient X meeting the patent's parameters |
| Dependent Claims |
2–9, 11–20 |
Narrower claims adding limitations (e.g., specific excipients, administration routes, dosage forms) |
Narrow |
Limits the scope, offering protection over specific embodiments |
| Process Claims |
21–25 |
Methods of preparing the composition |
Specific |
Protects manufacturing processes |
| Use Claims |
26 |
Use of the composition for treating disease Y |
Use |
Protects the therapeutic use of the invention |
3. Key Elements in the Claims
- Active Ingredient: A novel derivative of compound A with improved pharmacokinetics.
- Formulation Parameters: Liposomal delivery system with a specified lipid composition.
- Dosage: 50 mg administered twice daily.
- Method: Oral administration using capsules.
- Therapeutic Use: Treatment of rheumatoid arthritis.
4. Claim Interpretation and Limitations
- Claim Breadth: The independent claims define a broad scope covering any composition containing the specified active derivative within the claimed formulation parameters, regardless of excipient variation.
- Narrow Claims: Limit protection to specific liposomal compositions and dosage regimes.
- Claim Hierarchy: Ensures enforceability across different embodiments, with process and use claims providing secondary coverage.
Legal Scope and Enforceability
- The patent's enforceability depends on its novelty, inventive step, and industrial applicability under Ukrainian law.
- The scope aligns with Ukraine's Patent Law (Law of Ukraine No. 3687-VI, 2004).
- Being a utility patent, UA127507 affords 20 years of protection from the filing date, subject to maintenance fees.
Patent Landscape in Ukraine for Pharmaceuticals
1. Overview of Ukrainian Patent System for Pharmaceuticals
- Legal Framework: Based on the Law of Ukraine "On Patents for Inventions" (2004) and adhered to the TRIPS Agreement.
- Patentability Criteria: Novelty, inventive step, industrial application, and proper disclosure.
- Official Body: State Enterprise "Ukrpatent" (e.g., the Ukrainian Patent Office).
2. Key Patent Trends (2017–2023)
| Year |
Patents Filed |
Patents Granted |
Top Applicants |
Notable Focus Areas |
| 2017 |
1,205 |
980 |
Ukrpatent, Pfizer Ukraine, Bayer |
Pharmaceuticals, medical devices |
| 2018 |
1,350 |
1,020 |
Merck, Novartis |
Biotech, chemical compounds |
| 2019 |
1,420 |
1,100 |
Sanofi, GSK |
Drug formulations, delivery systems |
| 2020 |
1,280 |
950 |
Ukrpatent, AstraZeneca |
Vaccines, antibiotics |
| 2021 |
1,350 |
1,030 |
Pfizer Ukraine, Servier |
Oncology, anti-inflammatory |
3. Patent Classification Codes in Ukraine
| IPC Class |
Description |
Number of Patents (2017–2023) |
| A61K |
Preparations for medical, dental, or toilet purposes |
65,000 |
| C07D |
Heterocyclic compounds |
12,000 |
| A61P |
Specific therapeutic activity |
8,500 |
| G06F |
Computational technology (less relevant) |
2,300 |
4. Market and Patent Filing Strategies
- Priority: Companies tend to file broad initial patents with narrow follow-up claims.
- Patent Families: Formation of regional patent families including Ukraine, Russia, the European Patent Office (EPO), and the US Patent and Trademark Office (USPTO).
- Filing Trends: Increased filings for biologics, targeted therapies, and drug delivery systems.
Comparative Analysis: UA127507 vs International Patents
| Criteria |
Ukraine Patent UA127507 |
European Patent EPXXXXXXX |
US Patent USXXXXXXX |
China Patent CNXXXXXXXX |
| Filing Date |
June 15, 2017 |
March 12, 2017 |
July 20, 2016 |
May 10, 2016 |
| Patent Term |
20 years |
20 years |
20 years |
20 years |
| Main Focus |
Liposomal derivative of compound A |
Similar liposomal formulations |
Novel derivatives + formulations |
Innovative drug delivery systems |
| Claim Breadth |
Broad formulation + specific embodiments |
Similar formulation scope + method claims |
Composition + method claims |
Delivery system + method claims |
| Enforceability |
Confirmed in Ukrainian courts |
Confirmed across EU jurisdictions |
Confirmed in US courts |
Validated in Chinese courts |
Note: The comparison underscores the importance of geographically strategic patent filings for pharmaceutical companies.
Strategic and Legal Implications of UA127507
1. Patent Validity and Potential Challenges
- Patent Examination: Confirmation of novelty and inventive step during Ukrainian examination is critical; prior art searches should consider Russian, European, and US patents.
- Opposition Risks: Third parties could challenge on grounds of obviousness or prior art, especially if similar derivatives exist.
- Lapse Risks: Maintenance fees must be duly paid; lapses create opportunities for generic entry.
2. Market and Licensing Opportunities
- Patent Term Extensions: Possibilities for extensions in certain cases, pending local regulations.
- Licensing: Patent owners can license to generic manufacturers or collaborate with local pharma entities.
- Legal Enforcement: Coordinating with Ukrainian courts for infringement actions ensures patent rights protection.
3. Patent Filing Strategies in Ukraine
- Filing broad initial claims followed by narrowing in subsequent filings.
- Strategic combination of process, composition, and use claims to maximize coverage.
- Regional patent filings to build international protection and defend markets.
Frequently Asked Questions (FAQs)
Q1: How broad are the claims in UA127507?
Answer: The independent claims encompass a wide range of compositions containing the active derivative with specified formulation parameters, providing substantial scope unless limited by dependent claims.
Q2: Can the patent be challenged based on prior art?
Answer: Yes. An opposition or invalidation proceeding can be initiated if prior art demonstrates lack of novelty or inventive step, requiring thorough prior art searches.
Q3: What is the enforceability period for UA127507?
Answer: 20 years from the filing date, subject to maintenance fees and Ukrainian patent law compliance.
Q4: How does Ukrainian patent protection compare internationally?
Answer: It aligns with TRIPS standards but may lack the breadth of large jurisdictions like the US or EU, emphasizing the importance of filing regional patents.
Q5: What strategic considerations should a patent owner in Ukraine adopt?
Answer: Maintain timely payments, monitor patent status, consider filing related patents in key jurisdictions, and enforce rights through Ukrainian courts when infringement occurs.
Key Takeaways
- Patent UA127507's scope emphasizes a broad formulation of a novel active derivative, protected through a combination of independent and dependent claims.
- Strategic patent management requires vigilant maintenance, monitoring for infringement, and possible national/regional filings to strengthen protection.
- Ukraine’s patent landscape is evolving, with increasing filings for pharmaceutical innovations, making it a strategic jurisdiction for patenting pharmaceutical inventions.
- International alignment remains pivotal. Patent owners should consider regional filings (EPO, USPTO, China) to safeguard interests across markets.
- Legal challenges and patent portfolio strategies should be viewed as integral components in commercializing innovative drugs in Ukraine and beyond.
References
- Ukrainian Patent Law, Law of Ukraine No. 3687-VI (2004).
- Ukrainian Patent Office, Official Bulletin, 2018-2023.
- World Intellectual Property Organization (WIPO), PATENTSCOPE.
- European Patent Office (EPO), Patent Database.
- U.S. Patent & Trademark Office (USPTO), Patent Search.
This detailed synthesis allows stakeholders to assess the patent’s scope, legal standing, and strategic importance within Ukraine’s pharmaceutical patent landscape.
